Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions

Brazilian Journal of Pharmaceutical Sciences

Volumn 46, Issue 2, 2010, Pages 343-351

  Alves, Ricardo ^a   Reis, Thaís Vitória Da Silva ^a   Da Silva, Luis Carlos Cides ^a   Storpírtis, Silvia ^a   Mercuri, Lucildes Pita ^b   Matos, Jivaldo Do Rosário ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Kinetic analysis; Rifampicin; Thermal analysis; Thermal decomposition; Tuberculosis

Indexed keywords

RIFAMPICIN DERIVATIVE; RIFAMPICIN;

ARTICLE; DRUG DECOMPOSITION; KINETICS; PARAMETER; TEMPERATURE MEASUREMENT; TEMPERATURE SENSITIVITY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; MELTING POINT; TEMPERATURE; THERMAL ANALYSIS; THERMOGRAVIMETRY; THERMOSTABILITY;

EID: 77956418878     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502010000200022     Document Type: Article

References (22)

1. AGRAWAL, S., ASHOKRAJ, Y, BHARATAM, P.V., PILLAI, O, PANCHAGNULA, R. Solid state characterization of rifampicin samples and its biopharmaceutic relevance. Eur. J. Pharm. Sci., v.22, p.127-144, 2004.
2. ARAÚJO, A. A. S.; STORPIRTIS, S.; MERCURI, L. P.; CARVALHO, F.M.S.; SANTOS FILHO, M.; MATOS, J.R. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int. J. Pharm., v.260, p.303-314, 2003.
3. BACCHI, A., PELIZZI, G., NEBULONI, M., FERRARI, P. Comprehensive study on structure-activity relationships of rifamycins: Discussion of molecular and crystal structure and spectroscopic and spectroscopic and thermochemical properties of rifamycin. J. Med. Chem., v.41, p.2319-2332, 1998.
4. BUJNOWSKI, K, SYNORADZKI, L. DINJUS, E., ZEVACO, T., AUGUSTYNOWICZ-KOPEC, E., ZWOLSKA, Z. Rifamycin antibiotics - new compounds and synthetic methods. Part 1: Study of the reaction of 3-formylrifamycin SV with primary alkylamines or ammonia. Tetrahedron, v.59, p.1885-1893, 2003.
5. CARVALHO, W. S. , MIRANDA, S.S., PESQUERO, J.L., GOMES, M.A. Diagnóstico de resistência do Mycobacterium tuberculosis à rifampicina utilizando-se da reação em cadeia da polimerase. Rev. Bras. Ciênc. Farm., v.43, p.31-38, 2007.
6. CIDES, L.C.D., ARAÚJO, A.A.S., SANTOS-FILHO, M., MATOS, J.R. Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isotermal conditions. J. Therm. Anal. Calorim., v.84, p.441-445, 2006.
7. FORD, J.L.; TIMMINS, P. Pharmaceutical thermal analysis: Techniques and applications. New York: John Wiley & Sons, 1989. p.108-309.
8. GIRON, D. Contribution of thermal methods and related techniques to the rational development of pharmaceuticals-Part 1. Pharm. Sci. Technol. Today, v.1, p.191-199, 1998a.
9. GIRON, D. Contribution of thermal methods and related techniques to the rational development of pharmaceuticals-Part 2. Pharm. Sci. Technol. Today, v.6, p.262-268, 1998b.
10. HENWOOD, S.Q., DE VILLIERS, M.M., LIEBENBERG, W., LÖTHER, A.P. Solubility and dissolution properties of generic rifampicin raw materials. Drug Dev. Ind. Pharm., v.26, p.403-408, 2000.
11. MATOS, J.R.; MERCURI, L.P.; ARAUJO, G.L.B. Aspectos gerais relativos ao desenvolvimento farmacotécnico de medicamento: análise térmica aplicada a fármacos e medicamentos. In: STORPIRTIS, S.; GONÇALVES, J.E.; CHIANN, C.; GAI, M.N. (Eds.). Biofarmacotécnica. Rio de Janeiro: Guanabara Koogan, 2009. p.32-65.
12. OZAWA, T. A new method of analyzing thermogravimetric data. Bull. Chem. Soc. Jpn., v.38, 1881-1886, 1965.
13. PANCHAGNULA, R., AGRAWAL, S. Biopharmaceutic and pharmacokinetics aspects of variable bioavailability of rifampicin. Int. J. Pharm.,v.271, p.1-4, 2004.
14. PARISE FILHO, R.; ARAUJO, A. A. S.; SANTOS FILHO, M.; MATOS, J.R.; SILVEIRA, M. A. B.; BRANDT, C. A. . Thermoanalytical characterization of potentially schistosomicide polymeric derivatives. J. Therm. Anal. Calorim., v.75, p.487-494, 2004.
15. PELIZZA, G., NEBULONI, M., FERRARI, P., GALLO, G.G. Polymorphism of rifampicin. Farmaco (Sci), v.32, p.471-481, 1977.
16. ROUQUEROL, J.; WADSÖ, I.; LEVER, T.J.; HAINES, P.J. Developments in nomenclature. In: BROWN, M., GALLAGHER, P. (Eds.). Handbook of thermal analysis and calorimetry. Recent advances, techniques and applications. Amsterdam: Elsevier, 2007. v.5, p 21-62.
17. SALTINI, C. Chemotherapy and diagnosis of tuberculosis. Resp. Med., v.100, p.2085-2097, 2006.
18. SINGH, S., MARIAPPAN, T. T., SANKAR, R., SARDA, N. SINGH, B. A critical review of probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. Int. J. Pharm., v.228, p.5-17, 2001.
19. VENKATARAM, S.; KHOHLOKWANE, M.; WALLIS, S.H., Differential scanning calorimetry as a quick scanning technique for solid state stability studies, Drug Dev. Ind. Pharm. v.21, p.847-855, 1995
20. WORLD HEALTH ORGANIZATION. Global tuberculosis control: surveillance, planning, financing. Genebra: WHO, 2006. 77 p.
21. WORLD HEALTH ORGANIZATION. Model list of essential medicines. 5.ed. Genebra: WHO, 2007. 61 p.
22. ZHANG, Y., The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol., v.45, p.529-64, 2005.